University of Foggia   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Foggia Italy (1999)

Organization Overview

First Clinical Trial
2007
NCT00710788
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

ASL FG, Italy | ASL Foggia | Nephrology Division, Medical School, University of Foggia | Ospedali Riuniti di Foggia | University of Foggia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Failure (Phase 4)

Hepatitis, Chronic (Phase 3)

Peritonitis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 8